Artiva Biotherapeutics Inc. (ARTV)
NASDAQ · Healthcare
Artiva Biotherapeutics Inc. EBITDA 2023–2025
Artiva Biotherapeutics Inc. annual/quarterly ebitda history and growth rate from 2023 to 2024. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Artiva Biotherapeutics Inc. ebitda for the quarter ending March 31, 2024 was -13.9 M.
- Artiva Biotherapeutics Inc. annual ebitda for 2025 was -87.2 M, a 34.48% increase from 2024.
- Artiva Biotherapeutics Inc. annual ebitda for 2024 was -64.9 M, a 128.31% increase from 2023.
- Artiva Biotherapeutics Inc. annual ebitda for 2023 was -28.4 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Artiva Biotherapeutics Inc. EBITDA — FAQ
Artiva Biotherapeutics Inc. (ARTV) ebitda over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ARTV's ebitda history?
The chart and table above show Artiva Biotherapeutics Inc.'s ebitda by year and by quarter, including the growth rate.